What are the indications for kidney surgery?

Kidney Surgery Indications

Partial nephrectomy is the standard treatment for all T1a renal masses (≤4 cm) when intervention is indicated, and should be prioritized for T1b tumors (4-7 cm) when technically feasible, particularly when renal function preservation is important. 1, 2

Primary Indications by Clinical Scenario

Small Renal Masses (T1a: ≤4 cm)

Partial nephrectomy is the standard of care for all patients requiring intervention with tumors amenable to this approach 1. This provides:

• Equivalent oncological outcomes to radical nephrectomy
• Superior renal function preservation
• Reduced risk of chronic kidney disease (CKD)
• Lower cardiovascular morbidity and mortality 3, 4

Alternative approaches:

• Thermal ablation (radiofrequency or cryoablation) for tumors <3 cm, particularly in patients with significant comorbidities or high surgical risk 1, 5
• Active surveillance for patients with life expectancy <5 years, high anesthetic risk, or significant comorbidities 1

Larger Tumors (T1b: 4-7 cm)

Partial nephrectomy remains the preferred approach when the tumor is amenable and there is need to preserve renal function 1, 6. However, radical nephrectomy is acceptable when:

• Tumor complexity precludes safe partial nephrectomy
• Partial nephrectomy would result in unacceptable morbidity even at experienced centers 1

Key consideration: Referral to a surgeon and center with expertise in partial nephrectomy should be considered before proceeding with radical nephrectomy 1.

Absolute (Imperative) Indications for Partial Nephrectomy

These situations mandate nephron-sparing approaches 3:

• Anatomically or functionally solitary kidney
• Bilateral synchronous renal cell carcinoma
• Von Hippel-Lindau syndrome (surgery when tumors approach 3 cm) 7
• Hereditary RCC syndromes (BHDS, HPRC, TSC) 7

Relative Indications for Nephron-Sparing Surgery

Consider partial nephrectomy in patients with 3, 2, 3:

• Preexisting CKD (GFR <45 mL/min/1.73m²)
• Conditions impairing renal function (diabetes, hypertension, kidney stones, chronic pyelonephritis)
• Young age
• Multifocal masses
• Confirmed proteinuria

Critical threshold: Refer to nephrology if GFR <45 or progressive CKD develops, especially with proteinuria 1, 2.

Indications for Radical Nephrectomy

Radical nephrectomy should be reserved for 1, 2:

1. Tumors with significant complexity not amenable to partial nephrectomy
2. Increased oncologic potential suggested by:
   • Larger tumor size (>7 cm)
   • Aggressive imaging characteristics
   • Renal mass biopsy findings
3. Tumor extension into inferior vena cava 8, 4

Important caveat: Radical nephrectomy should NOT be used when nephron-sparing is technically possible 8, 4. The increased risk of CKD, cardiovascular events, and mortality associated with radical nephrectomy makes it suboptimal when partial nephrectomy is feasible.

Cytoreductive Nephrectomy (Metastatic Disease)

Offer cytoreductive nephrectomy when 3:

• Substantial disease volume at primary site
• Low burden of metastatic disease
• Good performance status

Note: The role of cytoreductive nephrectomy in the era of modern targeted therapies requires careful patient selection.

Lymph Node Dissection

Recommended for 2, 8, 4:

• Palpable lymph nodes
• CT-detected enlarged lymph nodes

Not therapeutic but provides prognostic information. Routine lymphadenectomy does not improve survival 8, 4.

Adrenalectomy

Indicated when 8, 4:

• Large upper pole tumors
• Abnormal-appearing adrenal gland on imaging

Not indicated for normal-appearing adrenal glands or low-risk tumor locations.

Special Considerations

Hereditary Syndromes

• VHL disease: Partial nephrectomy when tumors approach 3 cm 7
• HLRCC: Total radical nephrectomy due to aggressive nature 7
• BHDS, HPRC, TSC: Conservative nephron-sparing approaches 7

Renal Mass Biopsy

Should be obtained 1, 2:

• Before active surveillance when results may alter management
• Before or at time of thermal ablation
• For risk stratification when treatment approach is uncertain

Active Surveillance Criteria

Absolute indications 1:

• High anesthetic/surgical risk
• Life expectancy <5 years

Relative indications 1:

• Significant risk of end-stage renal disease if treated
• Tumors <1 cm
• Life expectancy <10 years

Common Pitfalls to Avoid

1. Performing radical nephrectomy for small tumors when partial nephrectomy is feasible - This unnecessarily increases CKD risk and associated cardiovascular mortality 4

2. Failing to refer complex cases to experienced centers - Surgical expertise significantly impacts outcomes for partial nephrectomy 1

3. Not obtaining renal mass biopsy before thermal ablation - Biopsy should be performed before rather than concomitantly with ablation 5

4. Overlooking nephrology referral - Patients with GFR <45 or progressive CKD need nephrology consultation 1, 2

5. Using thermal ablation for tumors >3-4 cm - Higher local recurrence rates make this suboptimal 5